CASP3 and pancreatic neoplasm: In addition, XAV939 treatment reversed the increased expression of β-catenin, Bcl-2, MMP2, and MMP9 proteins and decreased expression of Bax and cleaved caspase-3 in ARHGAP30-silenced pancreatic cancer cells (Fig. 4e).